Based on the expression levels of TMEM52B in cancer tissues, we divided all NPC patients into high and low expression groups (Figure 1D); high TMEM52B expression was significantly associated with advanced tumor node metastasis stage and recurrence (Figure 1E,F). Here, TMEM52B is linked to neoplasm.